Skip to main content
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1977 Dec;21:99–105. doi: 10.1289/ehp.772199

Pharmacokinetics of vinylidene chloride in the rat.

M J McKenna, P G Watanabe, P J Gehring
PMCID: PMC1475348  PMID: 612464

Abstract

The metabolism of inhaled vinylidene chloride in rats represents a balance of biotransformation pathways leading to the formation of a reactive alkylating species which is normally detoxified by conjugation with glutathione. Detoxification of the reactive intermediate formed from inhaled VDC is dependent upon the availability of hepatic glutathione (GSH); as VDC exposure concentrations are increased, the fraction of the dose detoxified by conjugation with GSH decreases markedly, commensurate with depletion of hepatic GSH. This reactive intermediate in the absence of GSH alkylates hepatic macromolecules and causes cell death. Similarly, hepatic GSH plays a vital role in the detoxification of the reactive metabolite formed from inhaled vinyl chloride (VC). However, the dose--response relationships for the utilization of GSH and the accumulation of alkylating metabolites following inhalation exposure to either VDC or VC point to distinct differences which may explain the differing biological activities of the two materials. Finally, preliminary pharmacokinetic data for inhaled VDC in mice indicate an enhanced susceptibility to VDC by virtue of an increased ability for production of alkylating VDC metabolites over that observed in the rat. The importance of these findings in light of recent evidence for a carcinogenic effect of VDC in mice is discussed.

Full text

PDF
99

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Jaeger R. J., Conolly R. B., Murphy S. D. Effect of 18 hr fast and glutathione depletion on 1,1-dichloroethylene-induced hepatotoxicity and lethality in rats. Exp Mol Pathol. 1974 Apr;20(2):187–198. doi: 10.1016/0014-4800(74)90053-7. [DOI] [PubMed] [Google Scholar]
  2. Jollow D. J., Mitchell J. R., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther. 1973 Oct;187(1):195–202. [PubMed] [Google Scholar]
  3. Lee C. C., Bhandari J. C., Winston J. M., House W. B., Peters P. J., Dixon R. L., Woods J. S. Inhalation toxicity of vinyl chloride and vinylidene chloride. Environ Health Perspect. 1977 Dec;21:25–32. doi: 10.1289/ehp.772125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Maltoni C., Lefemine G. Carcinogenicity bioassays of vinyl chloride: current results. Ann N Y Acad Sci. 1975 Jan 31;246:195–218. doi: 10.1111/j.1749-6632.1975.tb51094.x. [DOI] [PubMed] [Google Scholar]
  5. Maltoni C. Recent findings on the carcinogenicity of chlorinated olefins. Environ Health Perspect. 1977 Dec;21:1–5. doi: 10.1289/ehp.77211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Sedlak J., Lindsay R. H. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem. 1968 Oct 24;25(1):192–205. doi: 10.1016/0003-2697(68)90092-4. [DOI] [PubMed] [Google Scholar]
  7. Watanabe P. G., McGowan G. R., Gehring P. J. Fate of (14C)vinyl chloride after single oral administration in rats. Toxicol Appl Pharmacol. 1976 May;36(2):339–352. doi: 10.1016/0041-008x(76)90013-2. [DOI] [PubMed] [Google Scholar]
  8. Watanabe P. G., McGowan G. R., Madrid E. O., Gehring P. J. Fate of [14C]vinyl chloride following inhalation exposure in rats. Toxicol Appl Pharmacol. 1976 Jul;37(1):49–59. doi: 10.1016/s0041-008x(76)80007-5. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES